BridgeMD
New treatment option for Depressive Symptoms
Official title Non-pharmacological Care for Depression in Cancer Patients Using VR and TMS
ClinicalTrials.gov ID: NCT06589544
What this study is testing
- What it's testing
- Despite its significant impact on individuals and healthcare systems, substantial gaps remain in the clinical and rehabilitative management of depression in oncology patients. Depression in cancer patients is often under-recognized and untreated, and screening tools and structured healthcare pathways are lacking.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Diagnosis of oncological disease in the last 5 years
- Diagnosis of Major Depressive Disorder, without psychotic symptoms, according to DSM-5 criteria
- 17-item Hamilton Rating Scale for Depression (HAM-D-17) (score ≥14)
- Age: 18 years or older
- Oncological disease in a non-advanced stage (Karnofsky Performance Status \> 80)
You likely can't join if
- Current or prior hospitalization in the next 6 months
- Planned surgery in the next 6 months
- Suicidal ideation
- Substance use
- History of significant head trauma, neurological disorders, intellectual deficits
- Recurrent seizures resulting from head trauma or conditions lowering seizure threshold
See the full eligibility criteria
- Diagnosis of oncological disease in the last 5 years
- Diagnosis of Major Depressive Disorder, without psychotic symptoms, according to DSM-5 criteria
- 17-item Hamilton Rating Scale for Depression (HAM-D-17) (score ≥14)
- Age: 18 years or older
- Oncological disease in a non-advanced stage (Karnofsky Performance Status \> 80)
- Current or prior hospitalization in the next 6 months
- Planned surgery in the next 6 months
- Suicidal ideation
- Substance use
- History of significant head trauma, neurological disorders, intellectual deficits
- Recurrent seizures resulting from head trauma or conditions lowering seizure threshold
- Concurrent use of medications that increase the risk of epileptic seizures (e.g., antipsychotics, tricyclics, theophylline)
- Glaucoma, retinal detachment, or other serious vision impairments that may prevent the use of virtual reality technology
- Severe problems with autonomous ambulation
The study team makes the final eligibility decision.
Where it's taking place
- Ferrara, FE, Italy
- Cagliari, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ferrara, FE, Italy; Cagliari, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.